Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ATX | Ann: Amplia Completes Dosing in Phase 1 Clinical Study of AMP945 | 10:45 | 5 | 577 | |||
|
|||||||
| ATX | Ann: Amplia Appoints New Non-Executive Director | 09:59 | 8 | 1.0K | |||
|
|||||||
| ATX | Thirty reasons to buy ATX (Amplia Therapeutics) | 31/03/21 | 20 | 8.1K | |||
|
|||||||
| ATX | Ann: Change of Registered Office and Principal Place of Business | 25/03/21 | 1 | 416 | |||
|
|||||||
| ATX | Ann: Appendix 2A - Exercise of Options | 24/03/21 | 0 | 177 | |||
|
|||||||
| ATX | News: ATX Amplia Therapeutics Says Co And Garvan Institute To Enter Collaboration Agreement | 18/03/21 | 0 | 193 | |||
|
|||||||
| ATX | Ann: Amplia and Garvan Institute Enter Collaboration Agreement | 18/03/21 | 11 | 1.8K | |||
|
|||||||
| ATX | Ann: Amplia Completes Single Dose Study of AMP945 | 17/03/21 | 10 | 1.5K | |||
|
|||||||
ASX News
Hot NewsSee All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $24.29M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 22.5¢ | $60.02K | 259.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 49347 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 3000 | 1 |
View Market Depth
| Last trade - 13.21pm 15/04/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
23.5¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 24.0¢ | 22.5¢ | 33416 | ||
| Last updated 14.43pm 15/04/2021 (live) ? | |||||
| ATX (ASX) Chart |